Anyang Cancer Hospital
Anyang Cancer Hospital
Anyang, China4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 / Phase 2 | 2026-05-05 | NCT06214143 | |
| IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer | Platinum-resistant Ovarian Cancer | Recruiting | Phase 1 / Phase 2 | 2026-05-04 | NCT05551507 | |
| A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC | TNBC | Enrolling by invitation | Phase 2 | 2026-01-29 | NCT07376629 | |
| JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 3 | 2025-09-12 | NCT06079983 |